Dynamk Capital is focused on partnering with Life Sciences companies to accelerate their growth and technology adoption of disruptive solutions and services.  We target the innovative services, tools and technologies that enable the discovery, development and production of life-saving therapies, delivering lower costs, and increasing access to medicines globally. 

 
 

Our team >

We understand entrepreneurs because we are entrepreneurs. We focus on underserved segments of capital markets, providing B2B tools and services companies in Life Sciences with unique perspective in strategy, operations, business development and commercialization to accelerate their growth.